FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

318166002: Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    2153201014 Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT core module
    2160832017 Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet en Synonym Active Only initial character case insensitive SNOMED CT core module
    46604201000001110 Bendroflumethiazide 2.5mg / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet Is a Diuretics with potassium false Inferred relationship Existential restriction modifier
    Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet Has active ingredient Diuretic false Inferred relationship Existential restriction modifier
    Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet Is a Product containing bendroflumethiazide and potassium false Inferred relationship Existential restriction modifier
    Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet Has active ingredient Potassium false Inferred relationship Existential restriction modifier
    Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet Has active ingredient Bendroflumethiazide false Inferred relationship Existential restriction modifier
    Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet Has active ingredient Bendrofluazide - chemical false Inferred relationship Existential restriction modifier
    Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
    Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet Is a Product manufactured as oral dose form false Inferred relationship Existential restriction modifier
    Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
    Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet Is a Product containing potassium in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
    Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet Has active ingredient Potassium chloride false Inferred relationship Existential restriction modifier
    Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet Has manufactured dose form Modified-release tablet false Inferred relationship Existential restriction modifier
    Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet Has active ingredient Potassium chloride false Inferred relationship Existential restriction modifier
    Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
    Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
    Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet Has specific active ingredient Bendroflumethiazide false Inferred relationship Existential restriction modifier
    Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet Has specific active ingredient Potassium chloride false Inferred relationship Existential restriction modifier
    Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet Has dispensed dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
    Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet Is a Virtual medicinal product false Inferred relationship Existential restriction modifier
    Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Bendrofluazide+potassium 2.5mg/7.7mmol m/r tablet - product Is a False Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet Inferred relationship Existential restriction modifier
    Centyl K modified-release tablets (LEO Pharma) Is a False Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet Inferred relationship Existential restriction modifier
    Bendroflumethiazide 2.5mg / Potassium 7.7mmol modified-release tablets 56 tablet Is pack of False Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet Inferred relationship Existential restriction modifier
    Bendroflumethiazide 2.5mg / Potassium 7.7mmol modified-release tablets 56 tablet Has VMP False Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start